Pembrolizumab monotherapy for advanced chordoma

Xianglin Hu; Chunmeng Wang; Wending Huang; Sean M. Barber; Wangjun Yan

doi:10.1016/S1470-2045(23)00395-9

Pembrolizumab monotherapy for advanced chordoma

Xianglin Hu, Chunmeng Wang, Wending Huang, Sean M. Barber, Wangjun Yan

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e399
Journal	The Lancet Oncology
Volume	24
Issue number	10
DOIs	https://doi.org/10.1016/S1470-2045(23)00395-9
State	Published - Oct 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(23)00395-9

Cite this

@article{47f1d3f14a6247afb5d5b22a7e2beb99,

title = "Pembrolizumab monotherapy for advanced chordoma",

author = "Xianglin Hu and Chunmeng Wang and Wending Huang and Barber, {Sean M.} and Wangjun Yan",

year = "2023",

month = oct,

doi = "10.1016/S1470-2045(23)00395-9",

language = "English (US)",

volume = "24",

pages = "e399",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "10",

}

TY - JOUR

T1 - Pembrolizumab monotherapy for advanced chordoma

AU - Hu, Xianglin

AU - Wang, Chunmeng

AU - Huang, Wending

AU - Barber, Sean M.

AU - Yan, Wangjun

PY - 2023/10

Y1 - 2023/10

UR - http://www.scopus.com/inward/record.url?scp=85172661427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85172661427&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(23)00395-9

DO - 10.1016/S1470-2045(23)00395-9

M3 - Letter

C2 - 37797637

AN - SCOPUS:85172661427

SN - 1470-2045

VL - 24

SP - e399

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 10

ER -

Pembrolizumab monotherapy for advanced chordoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this